- Perpetually Adaptive Enterprise Press tab for submenu items
Where adaptability meets advantage
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
Perpetually Adaptive Enterprise
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- Our Brand Press tab for submenu items
With you for the long run
Whether it’s running a marathon or helping businesses thrive in applying new technology innovations at scale, we understand what it takes to keep pushing the limits of what’s possible.
-
About Us
- Customer Stories Press tab for submenu items
Discover why customers choose TCS
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
-
Events
Upcoming events
29 Sep 2025 TCS BaNCS and Quartz at SIBOS 2025, Frankfurt22 Sep 2025 TCS Life Sciences Forum 2025 LondonView all03 Sep 2025 TCS at PostTrade 360°, Stockholm -
Analyst Recognition
-
Global Studies
- Build a future with us Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Build a future with us
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
Investor Relations
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
- Worldwide Press tab for submenu items
Global knowledge. Local support
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
-
Asia Pacific
-
Europe
-
Middle East & Africa
-
North America
-
United Kingdom
Top Results
Showing
10
01 - 07
You have these already downloaded
We have sent you a copy of the report to your email again.
Industries
Life Sciences
This will open an overlay
Patient-centered Care Models Taking Center Stage in Life Sciences
Read how patient-centric care models and pharma innovation are ushering new trends in life sciences to improve patient outcomes and enrich lives.
Related Insights
Learn how generative AI is redefining genetics by developing genome editing strategies, driving advancements in gene therapies and personalized medicine.
White Paper
27 May 2025
Join the TCS ADD™ forum at Pace Port™ London to explore AI/generative AI in clinical R&D and pharmacovigilance and how it is transforming life sciences.
Events
22 Sep 2025
Read how using intelligent technology to transform systematic literature reviews from multiple dimensions can help create a cost-effective process.
White Paper
02 Dec 2022
Healthcare
This will open an overlay
Patient-centered Care: Health and Wellness Redefined
TCS’ research and innovation enable healthcare firms to focus on patients’ health and wellness, and provide high-quality personalized, value-based care.
Related Insights
The TCS survey explains how connected care can enable new patient-centric, value-based care, helping healthcare providers reimagine their services. Learn more.
Article
21 Feb 2024
Cited as strengths are Tata Consultancy Services’ industry-specific solutions across the provider value chain, balanced shoring mix, and strong foothold in the North American market.
Analyst Reports
15 Jul 2025
Watch this video for insights on women’s empowerment in the life sciences and healthcare, and explore ways to eliminate gender disparity and unlock change.
video
08 Apr 2025
Solutions
TCS TwinX™
This will open an overlay
TCS Twinx ™: Enterprise Digital Twin Platform for Risk-Free Business Experiments
TCS TwinX platform helps organizations to build their enterprise digital twins by modelling key enterprise entities for a seamless customer journey. Learn how.
Related Insights
TCS and TM Forum are developing a Decision Intelligence framework to help communication service providers make faster, more accurate decisions and improve CX.
Blog
26 Oct 2023
Future technology will be based on digital twin technology. Learn how digital twin platforms can create positive transformation in both business and society.
Blog
15 May 2023
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
Join us at the life sciences event to learn how AI and generative AI can accelerate next-gen clinical R&D and enhance patient safety. Register now for the event.
Events
07 Aug 2024
Engage with our experts at the World Drug Safety Congress Americas 2024 to learn about AI in pharmacovigilance and our TCS ADD™ Safety platform. Join us now.
Events
09 Sep 2024
An interview with Debashis Ghosh, President, Business Group Head, TCS
The confluence of technology and science is transforming the healthcare industry. The use of AI-powered digital twin technology has the potential to revolutionize healthcare by delivering precise and reproducible care without intrusion or risk. The shift toward in-silico methods, including digital twins and Generative AI (GenAI), is revolutionizing how we approach drug research and development.
GenAI facilitates knowledge synthesis, molecule design, and clinical trials, enhancing efficiency and accuracy. GenAI's impact is evident in expedited market entry, cost-effectiveness, and personalized treatment, paving the way for a more responsive, affordable, and tailored healthcare system in line with the emerging trends in precision medicine.
Streamlined processes, accurate drug design, and support for knowledge synthesis have accelerated the journey from discovery to development. GenAI is becoming a foundational technology for organizations which can be applied broadly across the healthcare value chain. TCS is investing strategically in GenAI and contributing to client success in healthcare research and development.
Debashis Ghosh
President, Life Sciences, Healthcare, Energy, Resources, and Utilities, TCS
GenAI holds immense potential to transform drug discovery from trial-and-error to a more predictable, efficient, and personalized approach. It can significantly reduce the time and cost of bringing new drugs to market by making clinical trial outcomes more predictable.
Item 1 of 3
Related reading
Swipe Left
Swipe Right
Transformation starts here
Integrated ecosystems are key to better patient outcomes.
Talk to our experts
©2025 TATA Consultancy Services Limited
©2025 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Accessibility Declaration
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?